miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway

被引:78
作者
Gu, Wei [1 ]
Li, Xiaomei [1 ]
Wang, Jue [2 ]
机构
[1] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Coll Med, Xian 710049, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Biomed Engn, Xian 710049, Shaanxi, Peoples R China
关键词
miR-139; hepatocellular carcinoma; T-cell factor-4; beta-catenin; METASTASIS-INDUCING DNA; BETA-CATENIN; MICRORNA EXPRESSION; CANCER; COMPLEX; GENE; BINDING; REGION; RNAS; TCF;
D O I
10.3892/or.2013.2831
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
microRNAs (miRNAs) are key post-transcriptional regulators of gene expression in hepatocellular carcinoma (HCC), but their specific roles and functions have yet to be fully elucidated. In the present study, a significant downregulation of miR-139 expression was demonstrated in HCC samples and HCC cells using quantitative PCR (qPCR). Upregulation of miR-139 in vitro, attenuated HCC cell growth, migration/invasion and induced apoptosis. Based on computational and expression analysis, we noted that miR-139 can control the expression of T-cell factor-4 (TCF-4) as a target gene. A reporter assay with the 3UTR of TCF-4 cloned downstream of a luciferase gene showed decreased luciferase activity in the presence of miR-139, providing strong evidence that miR-139 is a direct regulator of TCF-4. Furthermore, we observed that restoration of TCF-4 activity resulted in effects that were similar to those following transfection of the miR-139 inhibitor into HCC cells. Finally, mechanistic investigation revealed that the overexpression of miR-139 suppressed the -catenin/TCF-4 transcriptional activity by targeting TCF-4. In conclusion, our study demonstrates that miR-139 downregulation is common in HCC and that overexpression of miR-139 expression inhibits cell proliferation and invasion, suggesting that miR-139 may provide a therapeutic strategy for the treatment of HCC patients.
引用
收藏
页码:397 / 404
页数:8
相关论文
共 29 条
[1]   Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer [J].
Arndt, Greg M. ;
Dossey, Lesley ;
Cullen, Lara M. ;
Lai, Angela ;
Druker, Riki ;
Eisbacher, Michael ;
Zhang, Chunyan ;
Tran, Nham ;
Fan, Hongtao ;
Retzlaff, Kathy ;
Bittner, Anton ;
Raponi, Mitch .
BMC CANCER, 2009, 9 :374
[2]   TCF: Lady justice casting the final verdict on the outcome of Wnt signalling [J].
Brantjes, H ;
Barker, N ;
van Es, J ;
Clevers, H .
BIOLOGICAL CHEMISTRY, 2002, 383 (02) :255-261
[3]   Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs [J].
Cai, XZ ;
Hagedorn, CH ;
Cullen, BR .
RNA, 2004, 10 (12) :1957-1966
[4]   Hepatocellular carcinoma: Current management and future trends [J].
Carr, BI .
GASTROENTEROLOGY, 2004, 127 (05) :S218-S224
[5]   Surgery and ablative therapy for hepatocellular carcinoma [J].
Cha, C ;
DeMatteo, RP ;
Blumgart, LH .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2002, 35 (05) :S130-S137
[6]   TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing [J].
Chendrimada, TP ;
Gregory, RI ;
Kumaraswamy, E ;
Norman, J ;
Cooch, N ;
Nishikura, K ;
Shiekhattar, R .
NATURE, 2005, 436 (7051) :740-744
[7]  
El-Tanani M, 2001, CANCER RES, V61, P5619
[8]   Regulatory region of metastasis-inducing DNA is the binding site for T cell factor-4 [J].
El-Tanani, MK ;
Barraclough, R ;
Wilkinson, MC ;
Rudland, PS .
ONCOGENE, 2001, 20 (14) :1793-1797
[9]   Hepatocellular carcinoma [J].
Forner, Alejandro ;
Llovet, Josep M. ;
Bruix, Jordi .
LANCET, 2012, 379 (9822) :1245-1255
[10]   Caught up in a Wnt storm: Wnt signaling in cancer [J].
Giles, RH ;
van Es, JH ;
Clevers, H .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2003, 1653 (01) :1-24